CFB (Complement Factor B)

Key component of the alternative complement pathway

Gene Information Card

Symbol CFB
Full Name Complement Factor B
Gene Type Protein coding
Chromosomal Location 6p21.33
NCBI Gene ID 629 ncbi.nlm.nih.gov/gene/629
Ensembl ID ENSG00000166226
UniProt ID P00751
OMIM ID 138470
HGNC ID 1037
Aliases BF, BFD, CFAB, CFBD, GBG, H2-Bf, PBF2

Description

The CFB gene encodes complement factor B, a serine protease that is a central component of the alternative complement pathway. Factor B binds to C3b to form the C3 convertase (C3bBb), which cleaves C3 to initiate the amplification loop of complement activation. This gene is located in the MHC class III region on chromosome 6. Mutations in CFB are associated with atypical hemolytic uremic syndrome (aHUS), C3 glomerulopathy, and age-related macular degeneration (AMD).

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Atypical hemolytic uremic syndrome (aHUS) Gain-of-function mutations in CFB lead to uncontrolled alternative pathway activation, causing endothelial damage and microvascular thrombosis. ClinVar, OMIM
C3 glomerulopathy (C3G) Dysregulation of the alternative pathway due to CFB mutations results in excessive C3 deposition in glomeruli. ClinVar, OMIM
Age-related macular degeneration (AMD) CFB variants (e.g., R32Q) alter complement activation, contributing to drusen formation and retinal degeneration. NCBI Gene, OMIM
Complement factor B deficiency Loss-of-function mutations cause impaired alternative pathway activity, leading to increased susceptibility to Neisseria infections. OMIM, ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 57.2 High
Adipose tissue 12.1 Medium
Lung 8.5 Medium
Kidney 6.3 Medium
Spleen 5.9 Medium
Pancreas 4.2 Low
Heart 3.1 Low
Brain 0.8 Not detected
Cell Line Expression
Cell Line nTPM Notes
HepG2 (liver) 62.5 High expression
A549 (lung) 15.3 Moderate expression
HEK293 (embryonic kidney) 8.7 Moderate expression
K562 (leukemia) 2.1 Low expression
MCF7 (breast) 1.4 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.95G>A (p.Arg32Gln) Missense Common in AMD Gain-of-function; increases C3 convertase activity
c.967A>G (p.Lys323Glu) Missense Rare in aHUS Gain-of-function; enhances C3b binding
c.1690C>T (p.Arg564Cys) Missense Rare in C3G Gain-of-function; stabilizes convertase
c.1A>G (p.Met1?) Start loss Very rare Loss-of-function; complete deficiency
Mutation functional classification

Loss of Function (LOF)

Rare start-loss or nonsense mutations cause complete CFB deficiency, impairing alternative pathway activation and increasing infection risk.

Gain of Function (GOF)

Missense mutations (e.g., R32Q, K323E, R564C) enhance C3 convertase stability or activity, leading to complement overactivation and diseases like aHUS, C3G, and AMD.

Dominant Negative (DN)

No well-characterized dominant-negative mutations reported for CFB.

Pathways

Alternative complement pathway (Reactome: R-HSA-173736)
Complement cascade (KEGG: hsa04610)
Staphylococcus aureus infection (KEGG: hsa05150)
Systemic lupus erythematosus (KEGG: hsa05322)

Protein Summary

Complement factor B (UniProt P00751) is a 764-amino-acid glycoprotein synthesized primarily in the liver. It circulates in plasma as a single-chain zymogen. Upon activation by factor D, it is cleaved into Ba and Bb fragments. The Bb fragment contains the serine protease domain and associates with C3b to form the alternative pathway C3 convertase (C3bBb). Factor B is essential for the amplification loop of complement activation, playing a critical role in innate immunity.

Related Products

Product name Cat.No. Species Gene ID
CFB Knockout HEK293 Cell Line EDJ-KQ50154 Human 629 Details Get a Quote
CFB Knockout HeLa Cell Line EDJ-KQ52716 Human 629 Details Get a Quote
CFB Knockout A-549 Cell Line EDJ-KQ61187 Human 629 Details Get a Quote
CFB Knockout HCT 116 Cell Line EDJ-KQ69679 Human 629 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: